Spravato Medicare spend in New Jersey
In 2024, 4 providers in New Jersey billed Medicare Part B $1,683,091 for esketamine administration across 1,746 sessions and 144 patients, ranking 2 of 19 states and making up 12.3% of national dollars, +61% against 2023.
Medicare paid
$1.7M
12.3% of national
Sessions billed
1,746
G2082 + G2083 services
Patients
144
12.1 sessions per patient
Providers billing
4
$421k per provider
Year over year
Medicare dollars billed in New Jersey by data year.
Providers billing in New Jersey
Ranked by Medicare dollars, 2024.
How to read this
How much does Medicare spend on Spravato in New Jersey?
The totals above cover Medicare Part B fee-for-service payments for esketamine administration billed by providers with a New Jersey practice address, aggregated by rendering NPI.
Which providers bill it?
Every New Jersey rendering NPI in the CMS file is listed, ranked by dollars, with a link to that provider's own page.
What is missing?
Medicare Advantage, Medicaid and commercial payers are not in the file, and CMS suppresses provider-code combinations with fewer than eleven patients. Treat these figures as a floor, not the full market.
Where does the data come from?
CMS Medicare Physician & Other Practitioners — by Provider and Service, HCPCS G2082 and G2083, data year 2024.
Page: /spravato-market-dashboard/new-jersey. Source: CMS public use file, 2024.
Build the list for one county and see whether the names are right.
Ask in plain language. RepVector finds the universe, enriches each target from its own website, scores it 0–100, and hands you a ranked call list with phones, addresses and named contacts.
3 free runs — no card required.